<DOC>
	<DOCNO>NCT00295737</DOCNO>
	<brief_summary>The primary objective study isolate macrophage use bronchoalveolar lavage ( BAL ) different vitro experiment . Therefore , follow baseline BAL , allergen , endotoxin , saline instill three different lung segment first bronchoscopy . After 24 hour second bronchoscopy , BAL fluid collect challenged segment harvest invaded cell vitro experimentation . In addition , segmental bronchial biopsy take assess degree local inflammation .</brief_summary>
	<brief_title>Effect Immunotoxin Activated Human Macrophages Those With Allergic Rhinitis Mild Intermittent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Immunotoxins</mesh_term>
	<criteria>Physician diagnosis atopy ( allergic rhinitis mild intermittent asthma ) Age 1855 year Nonsmoker ( &gt; 5 year ) Forced expiratory volume 1 second ( FEV1 ) &gt; 70 % predict value A positive skin prick test grass mix D. pteronyssinus within 12 month prior screen visit Informed consent Females negative pregnancy test Infections respiratory tract within last month Past present disease , judge investigator , may affect outcome study . These disease include , limited , cardiovascular disease , malignancy , hepatic disease , renal disease , hematological disease , neurological disease , endocrine disease pulmonary disease ( include confine chronic bronchitis , emphysema , tuberculosis , bronchiectasis cystic fibrosis ) . Pathological finding blood test ( differential blood count , blood clotting , electrolytes , liver enzymes , retention parameter ) Subject undergo allergen desensitization therapy Permanent medication Systemic inhale corticosteroid use within last month Antiinflammatory medication within last month Pregnancy Neurological psychiatric disease history drug alcohol abuse would interfere subject 's proper completion protocol assignment There risk noncompliance study procedure Participation clinical trial 30 day prior enrolment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>allergic rhinitis</keyword>
</DOC>